#sustained virologic response

Adding ribavirin led to more side effects but did not improve the likelihood of a cure.

Drug-related mortality, including overdose, was the leading cause of death.

Recent drug use along with unstable housing increased the risk of acquiring HCV again.

The burden of viral and nonviral liver disease remains high even in the setting of hepatitis C microelimination.

However, people with liver cirrhosis remain at risk and should continue screening even after being cured.

The short treatment could make transplantation of organs from donors with HCV more safe, effective and economical.

Pairing HCV testing and treatment eliminates the need to navigate the medical system.

People who received a shortened course of antiviral therapy were less likely to be cured.

The risk was lower in people who had achieved a sustained virological response compared with those who had not.

If your previous treatment for hep C resulted in failure, can you undergo treatment again? This question, and others, answered here.

Premature discontinuation of hepatitis C treatment did not diminish the likelihood of sustained virological response.

Sustained response to direct-acting antivirals prolonged survival by a year and a half.

Once you’ve officially rid yourself of hepatitis C, how certain can you be that the virus is gone for good?

Treatment for hep C is easier than ever before. In clinical trials, roughly 95 percent of those who took the newest meds were cured.

Ridding the body of hep C reduces central fatigue, which is weakness originating in the central nervous system.

Sofosbuvir and ribavirin cured between 67 and 88 percent of those coinfected with HIV and genotypes 1, 2 or 3 of hepatitis C virus in a recent...